Cargando…

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial

A six-month, multicenter, randomized, open-label study was undertaken to determine whether renal function is improved using reduced-exposure cyclosporine (CsA) versus standard-exposure CsA in 199 de novo heart transplant patients receiving everolimus and steroids ± induction therapy. Mean C(2) level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuckermann, Andreas, Wang, Shoei-Shen, Ross, Heather, Frigerio, Maria, Eisen, Howard J., Bara, Christoph, Hoefer, Daniel, Cotrufo, Maurizio, Dong, Gaohong, Junge, Guido, Keogh, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268050/ https://www.ncbi.nlm.nih.gov/pubmed/22295178 http://dx.doi.org/10.1155/2011/535983

Ejemplares similares

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
por: Chapman, William C., et al.
Publicado: (2017)

The role of everolimus in liver transplantation
por: Ganschow, Rainer, et al.
Publicado: (2014)

Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results
por: Takahashi, Kota, et al.
Publicado: (2013)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
por: Bohra, Rahul, et al.
Publicado: (2012)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study
por: Noreikaitė, Aurelija, et al.
Publicado: (2017)

Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome
por: Tahar, Gargah, et al.
Publicado: (2010)

Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
por: Holdaas, Hallvard, et al.
Publicado: (2016)

Successful Treatment of Steroid-Dependent Eosinophilic Cellulitis With Cyclosporine
por: Kim, Su Hee, et al.
Publicado: (2013)

Simultaneous Determination of Cyclosporine A, Tacrolimus, Sirolimus, and Everolimus in Whole-Blood Samples by LC-MS/MS
por: Karapirli, Mustafa, et al.
Publicado: (2012)

Everolimus in Heart Transplantation: An Update
por: Hirt, Stephan W., et al.
Publicado: (2013)

Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children
por: Nikibakhsh, A. A., et al.
Publicado: (2011)

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
por: De Simone, P, et al.
Publicado: (2012)

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
por: Sommerer, Claudia, et al.
Publicado: (2018)

Everolimus – a new approach in the treatment of renal cell carcinoma
por: Anandappa, G, et al.
Publicado: (2010)

Design and rationale of the ATHENA study – A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial
por: Sommerer, Claudia, et al.
Publicado: (2016)

Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study
por: Actis, Giovanni C, et al.
Publicado: (2007)

Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review
por: Shah, Syed Raza, et al.
Publicado: (2016)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020)

Cyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation
por: Lee, Su Hyung, et al.
Publicado: (2017)

TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report
por: Iwasaki, Takahide, et al.
Publicado: (2022)

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
por: Eisenberger, Ute, et al.
Publicado: (2018)

No Association Between Cyclosporine Levels and Dyslipidemia?
por: Filler, Guido
Publicado: (2014)

Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

Effectiveness of cyclosporine as a treatment for steroid-resistant Cronkhite-Canada syndrome; two case reports
por: Yamakawa, Kohei, et al.
Publicado: (2016)

Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis
por: Ganzleben, Ingo, et al.
Publicado: (2020)

Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

Cyclosporine treatment for steroid-resistant nephrosis complicated with acquired hemophilia A: a case report
por: Alsultan, Mohammad, et al.
Publicado: (2023)

Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013)

Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2020)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study
por: Prasad, N., et al.
Publicado: (2018)

Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated with Cyclosporine and Tapered Steroid Therapy
por: Mayu, Saito, et al.
Publicado: (2019)

Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria
por: Ladapo, Taiwo Augustina, et al.
Publicado: (2016)

Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study
por: Thierry, A., et al.
Publicado: (2014)

Validation of a simple liquid chromatography coupled to tandem mass spectrometry method for the simultaneous determination of tacrolimus, sirolimus, everolimus and cyclosporin A in dried matrix on paper discs
por: Bressán, Ignacio Guillermo, et al.
Publicado: (2021)

Is Cyclosporine Ototoxic?
por: Waissbluth, Sofia
Publicado: (2020)

Effects of Cyclosporin A Therapy Combined with Steroids and Angiotensin Converting Enzyme Inhibitors on Childhood IgA Nephropathy
por: Shin, Jae Il, et al.
Publicado: (2010)

Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?
por: Eun, Chang Soo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0rf8ce9543250apeotegt4c30p